Literature DB >> 18193668

Therapy of herpes virus infections in children.

Richard J Whitley1.   

Abstract

Significant progress has been made in the treatment of viral infections in children, particularly those caused by HSV, varicella-zoster virus and cytomegalovirus. While not discussed in this review, licensed therapies are available for influenza infection in children as well. However, and notably so, numerous viral diseases of children represent unmet medical needs and warrant dedicated drug discovery efforts, including hepatitis B and C, and respiratory syncytial virus, among others.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18193668     DOI： 10.1007/978-0-387-73960-1_16

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


  4 in total

1.  Dysregulated Glycoprotein B-Mediated Cell-Cell Fusion Disrupts Varicella-Zoster Virus and Host Gene Transcription during Infection.

Authors:  Stefan L Oliver; Edward Yang; Ann M Arvin
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

2.  S-methylisothiourea induces apoptosis of herpes simplex virus-1-infected microglial cells.

Authors:  Yuan-Jin Guo; Wei Li; Xiao-Feng Li; Lei Zhao; Shu-Ling Zhang; Yu Zhou; Ji-Hua Dong; Yuan-Wu Mei
Journal:  Inflammation       Date:  2011-10       Impact factor: 4.092

3.  Pharmacokinetics and safety of famciclovir in children with herpes simplex or varicella-zoster virus infection.

Authors:  X Sáez-Llorens; R Yogev; A Arguedas; A Rodriguez; M G Spigarelli; T De León Castrejón; L Bomgaars; M Roberts; B Abrams; W Zhou; M Looby; G Kaiser; K Hamed
Journal:  Antimicrob Agents Chemother       Date:  2009-03-09       Impact factor: 5.191

4.  Single-dose pharmacokinetics of famciclovir in infants and population pharmacokinetic analysis in infants and children.

Authors:  Jeffrey Blumer; Adib Rodriguez; Pablo J Sánchez; William Sallas; Guenther Kaiser; Kamal Hamed
Journal:  Antimicrob Agents Chemother       Date:  2010-02-16       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.